Posted by AGORACOM-JC
at 6:40 PM on Monday, April 26th, 2021
When the Facebook data privacy scandal broke out, the world woke up to just how badly our individual data was being traded, used and most importantly, the amount of profit being generated by major corporations at our expense.
This led to the enactment of the biggest data privacy laws in history. Specifically, General Data Protection Regulation (GDPR) out of Europe and the California Consumer Privacy Act (CCPA).
Enter LQID (formerly KABN). The Company Turns The Problem Of Data Privacy Into A Profit For Individuals, While Providing Big Businesses With New & Compliant Business Models.
More than just lip service, $LQID has made some major announcements, including joining the Trust Over IP Foundation, which includes over 170 members including IBM, Mastercard, Accenture and many other global leaders who are defining a complete architecture for Internet-scale digital trust.
Does that sound like a mouthful? Yeah, it does. But all you have to really understand for now is that digital ID, privacy and monetization is going to become a reality in the very near future. Government regulations are enforcing it. Consumers are demanding it and $LQID is delivering it at such an advanced scale that the Trust Over IP Foundation provided them with a strategic role as a Steering Member.
If that wasn’t enough proof for you, Google validated the $LQID business model with this stunning announcement at the beginning of March:
Google believes these types of tracking methods don’t “meet rising consumer expectations for privacy, nor will they stand up to rapidly evolving regulatory restrictions, and therefore aren’t a sustainable long term investment.”
Google is experimenting with tools in its Privacy Sandbox that are designed to allow advertising to continue to work on the web but in a less privacy-encroaching way.
“Keeping the internet open and accessible for everyone requires all of us to do more to protect privacy — and that means an end to not only third-party cookies, but also any technology used for tracking individual people as they browse the web,” David Temkin, Google’s director of product management for ads privacy and trust,
What is the potential outcome of this major shift by Google?
“Google’s decision could upend the ad industry, which has relied on these types of tracking tools”
Now the data privacy and monetization game is underway with LQID sitting in a great position within the industry and the dominant position within the small cap world. That dominant position got even stronger today when $LQID announced the Launch Of KABN Prepaid Visa Card and Mobile Card App in Canada
WHY IS THIS SO IMPORTANT?
If consumers are going to switch to Liquid Avatar to protect and monetize their identity, they are also going to need ways to pay for the great individualized offers presented to them, which means $LQID has just added another super valuable piece of the puzzle to its solution
Watch this interview with CEO David Lucatch for an even deeper discussion into what this all means for $LQID and YOU.
Posted by AGORACOM-JC
at 7:02 PM on Sunday, April 25th, 2021
Maitri Health Technologies is a global platform for healthcare supply security whose main focus provides a reliable source of certified PPE (personal protective equipment) and testing solutions through an onshore manufacturing model.
This model has led to the creation of innovative and industry leading products including 3D certified surgical masks and patent-pending face shields, all integrated with technology to help track, trace and enable safer workplaces and communities.
It all takes place against a backdrop of huge potential: the global personal protective equipment market size is expected to reach USD 123.38 billion by 2027, registering a CAGR of 9.6%.
After previously securing Health Canada approval for its domestically manufactured N95masks, the company has had a trio of big announcements over the course of the last month:
Maitri has been asked by the British Columbia Ministry of Jobs, Economic Recovery & Innovation to join a government-supported virtual trademission to the United Kingdom.
Andrew McCann, a digital innovator in cloud platforms and online user experiences, and co-founder of DeviantArt, has joined the company as Chief Technology Officer.
Maitri has appointed Bridget Ross, CEO of Israel-based MedTech company ChroniSense Medical, to its Advisory Board.
Andrew Morton, Maitri’s CEO, talks us through the developments:
Our CEO and CMO spoke with Streetwise Reports about how Cedar Clinical Research is positioned to develop a new option for treatment-resistant depression.
On April 19, 1943, chemist Albert Hofmann took .00005 teaspoons of LSD. As he rode his bicycle home, he realized that the world had just changed. By Novamind CMO, Dr. Reid Robison and Kirsten Hirst.
More Americans died from drug overdoses in 2020 than ever before. As psychedelic-assisted treatment options approach mainstream medicine, Time looks at ibogaine as a way to treat addiction like few treatments can.
Psilocybin works. Researchers in London released findings from a phase 2 trial indicating that a couple of doses of psilocybin may treat depression as well as one of the most commonly prescribed antidepressants. More research is required but leaders of the study were surprised with the outcome.
Posted by AGORACOM-JC
at 6:01 PM on Friday, April 23rd, 2021
PK Beans is a revenue generating children’s wellness brand that is differentiating itself and super charging growth through great innovation and technology integration.
This is proven by the following:
Canada’s Only Public Company With Predominantly Female Board of Directors
Posted by AGORACOM-JC
at 4:42 PM on Friday, April 23rd, 2021
HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing a portfolio of high value-added silicon products sought after by battery and electric vehicle manufacturers.
If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:
To discuss the importance and the implications of this milestone, this excerpt from the press release says it all:
“Once the final equipment modifications are completed, the goal of the program will be to produce qualified samples which will then be tested by a third-party, the Institut National de Recherche Scientifique (INRS), and subsequently to awaiting battery manufacturers and automobile manufacturers.”
Peter Pascali, President and CEO of PyroGenesis added a little more excitement when he stated
“It is even more exciting when one considers the impact this could have on addressing the challenges facing the EV battery space.”
Watch this great interview with $HPQ CEO Bernard Tourillon to get the full picture on next steps!
Posted by AGORACOM-JC
at 4:23 PM on Thursday, April 22nd, 2021
Cardiol Therapeutics $CRDL.ca $CRTPF is a groundbreaking, clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease (heart/blood vessels).
The company has received approval from the U.S. FDA to commence a Phase II/III, double-blind, placebo-controlled clinical trial investigating the efficacy and safety of its lead clinical product, CardiolRx™, in treating hospitalized COVID-19 patients with a prior history of, or risk factors for, cardiovascular disease (CVD).
CardiolRx™ is an ultra-pure, high concentration cannabidiol oral formulation that is pharmaceutically produced, manufactured under cGMP and THC free.
Cardiol is also planning a Phase II international trial of CardiolRx™ in acute myocarditis, a condition caused by inflammation in heart tissue, most common cause of sudden cardiac death in people under 35.
The company is also developing proprietary cannabidiol formulations for the treatment of chronic heart failure.
One such key development is its commercial product, Cortalex™, an extra-strength formulation (100 mg/mL concentration) of cannabidiol oil that is pharmaceutically produced to be free of THC. Cardiol believes Cortalex™ to be the purest form of cannabidiol oil available in Canada.
It is the first THC-free extra-strength formulation of cannabidiol oil available across Canada exclusively online at Medical Cannabis by Canada’s largest pharmacy retailer, Shoppers Drugs Mart.
In March 2020, Cardiol signed a supplier agreement to become a medical cannabidiol supplier to Shoppers Drug Mart. The retailer will supply Cardiol’s pharmaceutical cannabidiol products to Shoppers for sale in all provinces and territories in Canada through Shoppers’ online store, Medical Cannabis by Shoppers.
And there’s plenty more to write home about:
~ $27M from exercise of warrants + equity raise since June 2020
Uplisting to NASDAQ
Team expansion with Chief Medical Officer hire
David Elsley, Cardiol Therapeutics’ President & CEO, gives us the low-down. Check it out:
Posted by AGORACOM-JC
at 4:16 PM on Thursday, April 22nd, 2021
When 99.8% of investors read the headline to this press release, you couldn’t blame them for not understanding what it meant or how important it is to the future of POET Technologies
POET Technologies Announces Entry into Telecom Market with 100G LR4 (Long Reach) Optical Engines
But this is the great thing about AGORACOM Beyond The Press Release, which provides investors with a layman’s understanding of both the importance of the technology and its importance to the bottom line of $PTK …. and they are both very important.
A couple of things we can say that all investors would understand are the following:
The addressable market for this product (100G LR4 Transceiver) is ~ $USD 200 Million per year.
POET believes it can capture a very meaningful percentage of this market.
A 100G LR4 transceiver sells for about 2X to 3X the price of status quo products but delivers significantly better performance
POET’s product significantly reduces the cost of the optical engine allowing it to provide a savings to customers in the range of 25%
This 25% savings to customers often means the difference for viability
POET has design an optical engine that uses 10% to 15% less power to deliver data at the same speed and over the same distance as comparable modules
From a capital markets point or view, the Company’s NASDAQ uplisting plan is progressing on schedule.
POET believes it will provide large US investors with the further de-risking they have requested in 2020
You don’t have to be a computer scientist to understand the value of all these points. But you do have to watch this powerful interview in its entirety to understand the big picture.
Posted by AGORACOM-JC
at 11:04 AM on Thursday, April 22nd, 2021
Watch this powerful interview with David Gandini, Chairman & Chief Revenue Officer SOBR Safe (SOBR: OTCQB) as he demonstrates the practical application of the SOBRCheck device and it’s profound implications in the workplace.
With SOBRCheck, employers are able to ensure their employees and general public are safe from alcohol related “accidents” where costs are measured in lives.
“Nearly 50% of industrial injuries and fatalities are alcohol related. Commercial Fleets suffer from over 11,000 alcohol related accidents every year. That rate is climbing and technology has failed to keep pace with this epidemic”
If you have ever wondered why a technology can’t be created to prevent the senseless amount of deaths and injuries every year on our roads and workplace you are not alone. SOBRSafe is doing something great about it and everyone should take the time to absorb the positive change possible by watching this interview.
